Kurt D’Andrea
Translational Therapeutics (United States)(US)University of Pennsylvania(US)
Publications by Year
Research Areas
Melanoma and MAPK Pathways, Cutaneous Melanoma Detection and Management, Cancer Genomics and Diagnostics, BRCA gene mutations in cancer, COVID-19 Clinical Research Studies
Most-Cited Works
- → Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanoma(2010)1,815 cited
- → Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications(2020)1,644 cited
- → T-cell invigoration to tumour burden ratio associated with anti-PD-1 response(2017)1,620 cited
- → The complete genome sequence of the hyperthermophilic, sulphate-reducing archaeon Archaeoglobus fulgidus(1997)1,422 cited
- → Acquired Resistance to BRAF Inhibitors Mediated by a RAF Kinase Switch in Melanoma Can Be Overcome by Cotargeting MEK and IGF-1R/PI3K(2010)1,226 cited
- → mRNA vaccines induce durable immune memory to SARS-CoV-2 and variants of concern(2021)916 cited
- →